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Background: Telethonin (TCAP) is a member of Z-disk proteins that play a pivotal role in cardiomyocyte structure and function. TCAP has been 
recently shown to associate and modulate the alpha subunit of the cardiac sodium channel Nav1.5. However, it has not been fully elucidated 
whether TCAP mutations are associated with Brugada Syndrome.
Methods: Mutational analysis for TCAP was performed on 286 Caucasian and 284 Japanese patients with Brugada syndrome (BrS). All patients 
were negative for voltage gated sodium channel, type V, alpha subunit (SCN5A) mutations. Using whole-cell patch-clamp technique, biophysical 
characteristics of hNav1.5 were studied in HEK293 cells stably expressing hNav1.5 and transiently transfected with wild-type or mutant TCAP.
Results: We identified three novel TCAP mutations: E49K, R153H and R106C. E49K and R153H were identified from BS syndrome patients 
and R106C in a patient who developed ECG changes consistent with Brugada type 1 ST elevation during propofol infusion. Electrophysiological 
experiments of these novel mutations demonstrated that the peak sodium currents were significantly reduced in the cells expressing R153H, E49K, 
and R106C-TCAP compared to the WT-TCAP (by 66% in R153H; by 72% in E49K; by 51% in R106C). The voltage dependency of the steady-state 
activation was leftward shifted in the R153H and R106C expressing cells by 6 mV and 4 mV, respectively. The voltage-dependency of the inactivation 
was leftward shifted in the E49K and R106C expressing cells by 5 mV and 3 mV, respectively. E49K and R106C mutations decreased the window 
currents.
Conclusion: We present the first evidence that the TCAP mutations identified in BrS patients can cause loss-of-function type modification of 
the cardiac sodium channel. The modification of hNav1.5 by mutant forms of TCAP may, in part, account for these patients’ electrophysiological 
phenotypes.
